Kamada (KMDA) Receivables - Net (2012 - 2026)
Kamada (KMDA) posted quarterly Receivables - Net of $36.5 million for Q1 2026, up 30.99% year-on-year from $27.9 million in Q1 2025, and up 35.21% on a QoQ basis from $27.0 million in Q4 2025.
Kamada (KMDA) Receivables - Net (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Receivables - Net for 15 consecutive years, with $36.5 million the latest figure, recorded in Q1 2026.
- Quarterly Receivables - Net rose 30.99% year-over-year to $36.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.5 million (up 30.99% YoY) and the FY2025 annual result came in at $27.0 million, up 25.34% from the prior year.
- Receivables - Net climbed to $36.5 million in Q1 2026 per KMDA's latest filing, from $27.0 million in the prior quarter.
- Over the last five years, Receivables - Net for KMDA reached as high as $36.5 million in Q1 2026 and fell as low as $20925.0 in Q1 2023.
- A 5-year average of $21.9 million and a median of $24.6 million in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2022 — Receivables - Net plunged 99.91% — and 2023, when it jumped 104525.58%.
- Year by year, Receivables - Net stood at $27.3 million in 2022, then dropped by 27.06% to $19.9 million in 2023, then increased by 8.4% to $21.5 million in 2024, then grew by 25.34% to $27.0 million in 2025, then soared by 35.21% to $36.5 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $36.5 million, $27.0 million, and $31.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.52 Mn |
| Mar 31, 2026 | 36.52 Mn |
| Dec 31, 2025 | 27.01 Mn |
| Dec 31, 2025 | 27.01 Mn |
| Sep 30, 2025 | 31.38 Mn |
| Sep 30, 2025 | 31.38 Mn |
| Jun 30, 2025 | 30.50 Mn |
| Jun 30, 2025 | 30.50 Mn |
| Mar 31, 2025 | 27.88 Mn |
| Mar 31, 2025 | 27.88 Mn |
| Dec 31, 2024 | 21.55 Mn |
| Dec 31, 2024 | 21.55 Mn |
| Sep 30, 2024 | 16.30 Mn |
| Sep 30, 2024 | 16.30 Mn |
| Jun 30, 2024 | 26.23 Mn |
| Jun 30, 2024 | 26.23 Mn |
| Mar 31, 2024 | 18.86 Mn |
| Mar 31, 2024 | 18.86 Mn |
| Dec 31, 2023 | 19.88 Mn |
| Dec 31, 2023 | 19.88 Mn |